Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 326

1.

Cross-protective peptide vaccine against influenza A viruses developed in HLA-A*2402 human immunity model.

Ichihashi T, Yoshida R, Sugimoto C, Takada A, Kajino K.

PLoS One. 2011;6(9):e24626. doi: 10.1371/journal.pone.0024626. Epub 2011 Sep 19.

2.

A CTL-based liposomal vaccine capable of inducing protection against heterosubtypic influenza viruses in HLA-A*0201 transgenic mice.

Matsui M, Kohyama S, Suda T, Yokoyama S, Mori M, Kobayashi A, Taneichi M, Uchida T.

Biochem Biophys Res Commun. 2010 Jan 15;391(3):1494-9. doi: 10.1016/j.bbrc.2009.12.100.

PMID:
20060099
3.

Infection of mice with a human influenza A/H3N2 virus induces protective immunity against lethal infection with influenza A/H5N1 virus.

Kreijtz JH, Bodewes R, van den Brand JM, de Mutsert G, Baas C, van Amerongen G, Fouchier RA, Osterhaus AD, Rimmelzwaan GF.

Vaccine. 2009 Aug 6;27(36):4983-9. doi: 10.1016/j.vaccine.2009.05.079. Epub 2009 Jun 16.

PMID:
19538996
5.

A pandemic influenza H1N1 live vaccine based on modified vaccinia Ankara is highly immunogenic and protects mice in active and passive immunizations.

Hessel A, Schwendinger M, Fritz D, Coulibaly S, Holzer GW, Sabarth N, Kistner O, Wodal W, Kerschbaum A, Savidis-Dacho H, Crowe BA, Kreil TR, Barrett PN, Falkner FG.

PLoS One. 2010 Aug 16;5(8):e12217. doi: 10.1371/journal.pone.0012217.

6.

Heterosubtypic protective immunity against influenza A virus induced by fusion peptide of the hemagglutinin in comparison to ectodomain of M2 protein.

Staneková Z, Király J, Stropkovská A, Mikušková T, Mucha V, Kostolanský F, Varečková E.

Acta Virol. 2011;55(1):61-7.

PMID:
21434706
8.

Cross-recognition of avian H5N1 influenza virus by human cytotoxic T-lymphocyte populations directed to human influenza A virus.

Kreijtz JH, de Mutsert G, van Baalen CA, Fouchier RA, Osterhaus AD, Rimmelzwaan GF.

J Virol. 2008 Jun;82(11):5161-6. doi: 10.1128/JVI.02694-07. Epub 2008 Mar 19.

9.

Enhanced protective immunity against H5N1 influenza virus challenge by vaccination with DNA expressing a chimeric hemagglutinin in combination with an MHC class I-restricted epitope of nucleoprotein in mice.

Tao P, Luo M, Pan R, Ling D, Zhou S, Tien P, Pan Z.

Antiviral Res. 2009 Mar;81(3):253-60. doi: 10.1016/j.antiviral.2008.12.009. Epub 2009 Jan 9.

PMID:
19135483
10.

Immunoinformatic comparison of T-cell epitopes contained in novel swine-origin influenza A (H1N1) virus with epitopes in 2008-2009 conventional influenza vaccine.

De Groot AS, Ardito M, McClaine EM, Moise L, Martin WD.

Vaccine. 2009 Sep 25;27(42):5740-7. doi: 10.1016/j.vaccine.2009.07.040. Epub 2009 Aug 4.

PMID:
19660593
11.

Critical role of TLR7 signaling in the priming of cross-protective cytotoxic T lymphocyte responses by a whole inactivated influenza virus vaccine.

Budimir N, de Haan A, Meijerhof T, Waijer S, Boon L, Gostick E, Price DA, Wilschut J, Huckriede A.

PLoS One. 2013 May 2;8(5):e63163. doi: 10.1371/journal.pone.0063163. Print 2013.

12.

Vaccination with whole inactivated virus vaccine affects the induction of heterosubtypic immunity against influenza virus A/H5N1 and immunodominance of virus-specific CD8+ T-cell responses in mice.

Bodewes R, Kreijtz JH, Hillaire ML, Geelhoed-Mieras MM, Fouchier RA, Osterhaus AD, Rimmelzwaan GF.

J Gen Virol. 2010 Jul;91(Pt 7):1743-53. doi: 10.1099/vir.0.020784-0. Epub 2010 Mar 24.

PMID:
20335492
13.

Protection against H1N1 influenza challenge by a DNA vaccine expressing H3/H1 subtype hemagglutinin combined with MHC class II-restricted epitopes.

Tan L, Lu H, Zhang D, Tian M, Hu B, Wang Z, Jin N.

Virol J. 2010 Dec 7;7:363. doi: 10.1186/1743-422X-7-363.

14.

Induction of heterosubtypic cross-protection against influenza by a whole inactivated virus vaccine: the role of viral membrane fusion activity.

Budimir N, Huckriede A, Meijerhof T, Boon L, Gostick E, Price DA, Wilschut J, de Haan A.

PLoS One. 2012;7(1):e30898. doi: 10.1371/journal.pone.0030898. Epub 2012 Jan 27.

15.

Cross-protective immunity against influenza A/H1N1 virus challenge in mice immunized with recombinant vaccine expressing HA gene of influenza A/H5N1 virus.

Yang S, Niu S, Guo Z, Yuan Y, Xue K, Liu S, Jin H.

Virol J. 2013 Sep 22;10:291. doi: 10.1186/1743-422X-10-291.

17.

Highly conserved sequences for human neutralization epitope on hemagglutinin of influenza A viruses H3N2, H1N1 and H5N1: Implication for human monoclonal antibody recognition.

Yamashita A, Kawashita N, Kubota-Koketsu R, Inoue Y, Watanabe Y, Ibrahim MS, Ideno S, Yunoki M, Okuno Y, Takagi T, Yasunaga T, Ikuta K.

Biochem Biophys Res Commun. 2010 Mar 19;393(4):614-8. doi: 10.1016/j.bbrc.2010.02.031. Epub 2010 Feb 10.

PMID:
20152806
18.

Antibody contributes to heterosubtypic protection against influenza A-induced tachypnea in cotton rats.

Straight TM, Ottolini MG, Prince GA, Eichelberger MC.

Virol J. 2008 Mar 20;5:44. doi: 10.1186/1743-422X-5-44.

19.

Variation at Extra-epitopic Amino Acid Residues Influences Suppression of Influenza Virus Replication by M158-66 Epitope-Specific CD8+ T Lymphocytes.

van de Sandt CE, Pronk MR, van Baalen CA, Fouchier RAM, Rimmelzwaan GF.

J Virol. 2018 May 14;92(11). pii: e00232-18. doi: 10.1128/JVI.00232-18. Print 2018 Jun 1.

PMID:
29593036
20.

Preclinical efficacy studies of influenza A haemagglutinin precursor cleavage loop peptides as a potential vaccine.

Miller DS, Finnie J, Bowden TR, Scholz AC, Oh S, Kok T, Burrell CJ, Trinidad L, Boyle DB, Li P.

J Gen Virol. 2011 May;92(Pt 5):1152-61. doi: 10.1099/vir.0.028985-0. Epub 2011 Feb 2.

PMID:
21289160

Supplemental Content

Support Center